Competition of adenine nucleotides for a 1,3-[3H]-dipropyl-8-cyclopentylxanthine binding site in rat vas deferens

Clinical and Experimental Pharmacology and Physiology

Volumn 24, Issue 7, 1997, Pages 492-497

  Smith, Andrew D ^a   Cheek, Dennis J ^a   Buxton, Iain L O ^a   Westfall, David P ^a  

^a UNIVERSITY OF NEVADA SCHOOL OF MEDICINE   (United States)

Author keywords

ATP; Nucleosides; Nucleotides; Purinoceptors; Radioligand binding; Vas deferens

Indexed keywords

2 CHLOROADENOSINE; 6 N CYCLOPENTYLADENOSINE; 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; ADENINE NUCLEOTIDE; ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE A1 RECEPTOR; ADENOSINE A1 RECEPTOR ANTAGONIST; ADENOSINE TRIPHOSPHATE; ADENYLATE KINASE; ALPHA,BETA METHYLENEADENOSINE TRIPHOSPHATE; BETA,GAMMA METHYLENEADENOSINE TRIPHOSPHATE; NUCLEOSIDE; NUCLEOTIDE; PHENYLISOPROPYLADENOSINE; PURINE RECEPTOR; RADIOLIGAND;

ANIMAL TISSUE; ARTICLE; COMPUTER ANALYSIS; CONTROLLED STUDY; DRUG BINDING SITE; DRUG POTENCY; ISOMER; MALE; NONHUMAN; RAT; RECEPTOR AFFINITY; RECEPTOR BINDING; RECEPTOR DENSITY; VAS DEFERENS;

EID: 0031006143     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1681.1997.tb01233.x     Document Type: Article

References (24)

1. Burnstock G. A basis for distinguishing two types of purinergic receptor. In: Straub RW, Bolis L (eds). Cell Membrane Receptors For Drugs and Hormones: A Multidisciplinary Approach. Raven Press, New York. 1978; 107-18.
2. Dalziel HH, Westfall DP. Receptors for adenine nucleotides and nucleosides: Subclassification, distribution, and molecular characterization. Pharmacol. Rev. 1994; 46: 449-66.
3. Su C. Purinergic neurotransmission and neuromodulation. Annu. Rev. Pharmacol. Toxicol. 1983; 23: 397-11.
4. Shinozuka K, Bjur RA, Westfall DP. Characterization of pre-junctional purinoceptors on adrenergic nerves of the rat caudal artery. Naunyn Schmiedeberg's Arch. Pharmacol. 1988; 338: 221-7.
5. Forsyth KM, Bjur RA, Westfall DP. Nucleotide modulation of norepinephrine release from sympathetic nerves in the rat vas deferens. J. Pharmacol. Exp. Ther. 1991; 256: 821-6.
6. Shinozuka K, Bjur RA, Westfall DP. Effects of α,β-methylene ATP on the prejunctional purinoceptors of the sympathetic nerves of the rat caudal artery. Eur. J. Pharmacol. 1990; 192: 431-4.
7. Ishii R, Shinozuka K, Hattori K et al. Purinergic facilitation of norepinephrine release from adrenergic nerves of rabbit ear artery. Proc. West. Pharmacol. Soc. 1993; 36: 17-20.
8. Todorov LD, Bjur RA, Westfall DP. Inhibitory and facilitatory effects of purines on transmitter release from sympathetic nerves. J. Pharmacol. Exp. Ther. 1993; 268: 985-9.
9. 2-purinoceptors. Br. J. Pharmacol. 1993; 110: 1465-72.
10. Von K gelgen I. Purinoceptors modulating the release of noradrenaline. J. Auton. Pharmacol. 1994; 14: 11-12.
11. 3 receptor. FASEB J. 1996; 10: A159.
12. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976; 72: 248-54.
13. 1 receptors in rat smooth muscle preparations. Br. J. Pharmacol. 1994; 113: 1249-56.
14. Coates J, Sheehan MJ, Strong P. 1,3-Dipropyl-8-cyclopentyl xanthine (DPCPX): A useful tool for pharmacologists and physiologists? Gen. Pharmacol. 1994; 25: 387-94.
15. 50) of an enzymatic reaction. Biochem. Pharmacol. 1973; 22: 3099-108.
16. Scatchard G. The attraction of proteins for small molecules and ions. Ann. N.Y. Acad. Sci. 1949; 51: 660-72.
17. 2x-purinoceptor ligands. Br. J. Pharmacol. 1994; 113: 1432-8.
18. Clanachan AS, Johns A, Paton DM. Presynaptic inhibitory actions of adenine nucleotides and adenosine on neurotransmission in the rat vas deferens. Neuroscience 1977; 2: 597-602.
19. Verhaeghe RH, Vanhoutte PM, Shepherd JT. Inhibition of sympathetic neurotransmission in canine blood vessels by adenosine and adenine nucleotides. Circ. Res. 1977; 40: 208-15.
20. Wakade AR, Wakade TD. Inhibition of noradrenaline release by adenosine. J. Physiol. 1978; 282: 35-49.
21. 3H]-noradrenaline from the rat isolated heart: Lack of relationship to prostaglandins. J. Pharmacol. Exp. Ther. 1980; 68: 551-61.
22. Paton DM. Presynaptic neuromodulation mediated by purinergic receptors. In: Burnstock G (ed.). Purinergic receptors. Chapman & Hall, London. 1981; 199-219.
23. Scheimann WP, Walther JM, Buxton ILO. On the ability of endogenous adenosine to regulate purine nucleoside receptor binding of antagonists in smooth muscle membranes. J. Pharmacol. Exp. Ther. 1990; 265: 886-92.
24. 3 adenosine receptor. Proc. Natl Acad. Sci. USA 1992; 89: 7432-6.